Abvc Biopharma ABVC Growth Metrics (2010-2026)

NASDAQ ABVC
$1.02 -0.04 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Abvc Biopharma Quarterly Growth Metrics

Periods 50 quarters
Latest Jun 2026

Abvc Biopharma growth metrics data for the quarter ended Jun 2026. These growth metrics cover 50 quarters of results from Sep 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y)
-0.09M-2.37M0.58M-0.68M2.27M-3.51M-0.47M-2.28M-23.40M3.51M1.34M-1.20M
EBITDA Margin Growth (3y)
4.96M-2.39M-0.04M-0.82M0.06M-839.00-3.53M-1.24M-1.55M-23.50M0.57M0.19M
EBITDA Margin Growth (5y)
0.51M-1.99M3.81M1.63M-23.51M-0.05M0.05M-3.42M
EBITDA Margin (QoQ)
0.45M2.36M-0.81M0.82M-0.10M-3.43M2.23M-0.98M-21.21M23.47M0.07M-3.52M
EBIT Margin Growth (1y)
-0.09M-2.38M0.58M-0.68M2.27M-3.53M-0.48M-2.31M-23.41M3.52M1.35M-1.22M
EBIT Margin Growth (3y)
5.11M-2.39M-0.04M-0.82M0.06M73.00-3.54M-1.25M-1.58M-23.51M0.57M0.19M
EBIT Margin Growth (5y)
-0.04M0.52M-1.97M3.95M1.63M-23.52M-0.05M0.05M-3.47M
EBIT Margin (QoQ)
0.45M2.36M-0.81M0.83M-0.10M-3.44M2.23M-1.01M-21.19M23.48M0.07M-3.58M
EBT Margin Growth (1y)
-0.01M-2.36M0.61M-0.69M2.26M-3.59M-1.23M-2.36M-24.15M3.56M2.11M-1.63M
EBT Margin Growth (3y)
9.93M-2.36M-0.03M-0.83M0.05M0.02M-3.56M-1.93M-1.61M-24.25M0.57M0.19M
EBT Margin Growth (5y)
-0.04M0.66M-1.14M8.00M11.17M-24.25M-0.06M0.05M-3.94M
EBT Margin (QoQ)
0.47M2.34M-0.83M0.83M-0.09M-3.51M1.54M-0.30M-21.87M24.20M0.09M-4.04M
FCF Margin Growth (1y)
-0.20M-1.15M0.35M0.10M1.09M-1.36M-0.47M-1.98M-7.82M1.45M0.59M-1.58M
FCF Margin Growth (3y)
2.59M-1.17M-0.07M-0.11M0.14M-0.04M-1.41M-0.56M-1.64M-7.88M0.44M0.23M
FCF Margin Growth (5y)
-0.09M0.41M-0.13M2.22M-2.89M-7.90M0.02M0.01M-3.42M
FCF Margin (QoQ)
0.24M1.09M-0.01M0.11M-0.11M-1.36M0.88M-1.40M-5.94M7.91M0.02M-3.57M
Gross Margin Growth (1y)
706.00-692.00-62.00-0.00M-0.00M-0.12M-0.02M-0.64M0.00M0.12M0.02M0.64M
Gross Margin Growth (3y)
0.01M-668.00429.00-0.00M-0.00M-0.00M-0.12M-0.02M-0.64M-0.00M189.0032.00
Gross Margin Growth (5y)
-267.000.00M-0.11M-0.01M-0.03M-0.00M680.00134.00249.00
Gross Margin (QoQ)
166.00471.00-0.00M-0.00M-190.00-0.11M0.10M-0.62M0.64M0.00M9.008.00
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
35.57%-536.45%-3,449.48%-463.30%42.36%91.19%90.15%86.22%93.98%71.24%53.56%78.27%22.44%51.49%80.11%-326.96%-4,526.38%-1,977.84%-924.62%-3.86%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-150.54%-196.14%-293.01%-235.16%-43.37%-30.62%-55.73%-31.04%71.83%45.57%-17.54%44.75%70.03%76.92%79.12%49.62%-29.28%-42.59%1.81%1.24%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
-93.88%-83.60%24.83%-39.76%-33.61%11.40%8.03%-22.67%-2.43%32.74%20.84%18.99%-15.85%4.31%-10.20%-27.05%5.64%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-106.93%-419.31%-29.05%59.38%78.83%20.65%-44.38%43.17%90.75%-279.02%-133.10%73.41%66.98%-137.05%4.40%-470.57%-257.79%-6.47%52.86%42.16%
Net Margin Growth (1y)
0.00M-2.29M0.57M-0.69M2.19M-3.65M-1.21M-15.86M-24.15M3.62M2.08M68.80M
Net Margin Growth (3y)
9.02M-2.30M-0.03M-0.81M0.03M0.02M-3.62M-1.90M-15.15M-24.25M0.54M0.18M
Net Margin Growth (5y)
-0.04M0.57M-1.43M7.11M-2.76M-24.25M-0.05M0.06M52.97M
Net Margin (QoQ)
0.44M2.28M-0.82M0.79M-0.06M-3.56M1.62M-13.86M-8.35M24.21M0.08M52.86M
Operating Margin Growth (1y)
-0.09M-2.38M0.58M-0.68M2.27M-3.53M-0.48M-2.31M-23.41M3.52M1.35M-1.22M
Operating Margin Growth (3y)
5.11M-2.39M-0.04M-0.82M0.06M73.00-3.54M-1.25M-1.58M-23.51M0.57M0.19M
Operating Margin Growth (5y)
-0.04M0.52M-1.97M3.95M1.63M-23.52M-0.05M0.05M-3.47M
Operating Margin (QoQ)
0.45M2.36M-0.81M0.83M-0.10M-3.44M2.23M-1.01M-21.19M23.48M0.07M-3.58M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
243.000.00M-0.00M-0.00M-0.01M-0.01M0.00M560.000.01M0.01M118.000.00M0.00M-72.000.01M0.01M0.00M0.00M-0.00M-953.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
0.01M0.00M-0.00M-0.00M-0.01M-0.01M405.000.00M-0.00M588.000.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.82M0.78M0.21M0.22M0.01M0.01M0.01M0.01M0.01M-0.00M-0.00M0.00M-0.00M0.01M0.01M0.00M0.01M
Return on Assets [ROA] (QoQ)ROA (QoQ)
0.00M248.00-0.00M125.00-0.00M-839.000.00M-521.000.00M0.00M-0.01M0.00M0.00M-341.000.00M-9.00-356.00-675.00-510.00588.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
0.10M0.01M-0.00M-388.00-0.01M-0.02M-0.00M-0.01M0.01M0.02M-0.02M-0.01M-0.01M-0.03M0.04M0.03M0.02M0.04M366.00-271.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
0.00M0.06M0.10M0.01M-0.03M-0.02M-0.01M-0.03M0.01M0.01M0.02M0.03M0.02M0.02M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
-0.00M0.06M0.11M0.02M0.01M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
0.00M0.00M-0.01M105.00-0.00M-0.01M0.01M-0.00M0.01M0.00M-0.03M0.01M0.01M-0.02M0.04M0.00M-217.00-133.00-577.00656.00
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
0.12M0.03M0.07M-233.00-0.02M-0.03M-0.06M0.00M0.02M-0.02M0.03M-0.01M-0.03M0.06M0.05M0.03M0.04M564.00-828.00
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.08M0.12M-0.02M0.04M-0.01M-0.03M0.01M0.02M0.02M0.03M0.04M0.07M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.06M0.08M0.13M0.04M0.09M
Return on Equity [ROE] (QoQ)ROE (QoQ)
0.07M0.01M-0.01M519.00-0.00M-0.01M-0.01M-0.03M0.06M0.01M-0.05M0.02M0.02M-0.01M0.04M0.00M95.00-894.00-955.00927.00
Return on Invested Capital [ROIC] Growth (1y)ROIC Growth (1y)
0.02M0.02M0.00M0.01M-0.00M-0.01M-0.03M0.00M0.01M0.02M-0.00M-0.01M0.02M0.01M0.02M
Return on Invested Capital [ROIC] Growth (3y)ROIC Growth (3y)
0.01M-0.01M0.01M0.03M0.02M0.00M-0.00M-0.01M0.01M0.02M0.02M
Return on Invested Capital [ROIC] Growth (5y)ROIC Growth (5y)
0.01M-0.01M0.05M0.04M0.02M
Return on Invested Capital [ROIC] (QoQ)ROIC (QoQ)
0.01M0.00M-0.01M200.00-0.00M-0.00M0.03M0.00M0.01M-0.01M-309.00-464.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.09M0.45M-2.38M0.58M-0.68M0.28M2.27M-3.53M-0.48M-2.31M-23.41M3.52M1.35M-1.22M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
5.11M3.66M-2.39M-0.04M-0.82M0.06M73.00-3.54M-1.25M-1.58M-23.51M0.57M0.19M-3.25M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.30M-2.24M-0.04M0.52M-1.97M3.95M1.63M-23.52M-0.05M0.05M-3.47M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.45M-0.13M-2.09M2.36M-0.81M0.83M-0.10M-3.44M2.23M-1.01M-21.19M23.48M0.07M-3.58M

Abvc Biopharma Growth Metrics API

Pull Abvc Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ABVC&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY